No Data
Medicai: Hangzhou Medikai Optoelectronics Technology Co., Ltd. 2024 Annual Performance Report Announcement
Hangzhou Medikai Optoelectronics Technology Co., Ltd. 2024 Annual Performance Report Announcement
Medicare (688079.SH): Net loss of 98.3054 million yuan for the fiscal year 2024.
Gelonghui reported on February 27 that Medikai (688079.SH) announced its performance report for the fiscal year 2024. The company achieved revenue of 486.5894 million yuan in 2024, an increase of 165.8648 million yuan compared to the same period last year, a year-on-year growth of 51.72%; it recorded a net income attributable to the parent company's owners of -98.3054 million yuan, a decrease of 13.8545 million yuan compared to the same period last year; the net income attributable to the parent company's owners excluding non-recurring gains and losses was -88.8818 million yuan, a decrease of 13.7219 million yuan compared to the same period last year. In 2024, based on
Medicae (688079.SH): Shareholder Fengshenjia has collectively reduced their shareholding by 0.9867%.
On February 20, 2025, Meidi Kai (688079.SH) announced that it received a notification from Shareholder Fengsheng Jiamei regarding the expiration of the Shareholding reduction plan and the results of the reduction. As of February 20, 2025, Fengsheng Jiamei reduced its shares by 4,013,333 shares through centralized bidding trading, and reduced 0 shares through block trading, totaling a reduction of 4,013,333 shares, accounting for 0.9867% of the company's total equity. The duration of this Shareholding reduction plan has expired, and the implementation of this Shareholding reduction plan has been completed.
Hangzhou Mdk Opto Electronics Co.,Ltd.'s (SHSE:688079) Share Price Not Quite Adding Up
Medicai: Hangzhou Medikai Optoelectronics Technology Co., Ltd. 2024 Annual Results Advance Loss Announcement
There's Reason For Concern Over Hangzhou Mdk Opto Electronics Co.,Ltd's (SHSE:688079) Massive 35% Price Jump